Invacare Compliance Challenges, Product Delays Impact Q3 Results
This article was originally published in The Gray Sheet
Executive Summary
Talks with FDA are ongoing about compliance with quality system regulations and a proposed consent decree that would shut down certain operations at a wheelchair manufacturing plant in Elyria, Ohio, executives said during the firm’s Oct. 25 earnings call.